Search Results 1291-1300 of 17002 for pharmacogenetics
Dawn Lenhardt's life changed when she was diagnosed with cancer. But, she learned a type of treatment without losing her hair was available, allowing her to ...
Graduate students and postdoctoral fellows interested in metabolic reprogramming of immune cells in the tumor microenvironment and the targeting of tumor ...
The purpose of this study is to evaluate the safety and effectiveness of nonconforming idecabtagene vicleucel (ide-cel) in subjects with multiple myeloma per ...
This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.
Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.
The purpose of this study is to evaluate the clinical efficacy, safety, and tolerability of XEN1101 administered as adjunctive treatment in primary generalized ...
The purpose of this study is to understanding the mechanisms of weight gain in patients following liver transplantation, action, and indicate approaches to ...
Learn about causes and treatment of this blood disorder that mainly affects women and may cause blood clots and miscarriages.
As scientists at the Mayo Clinic Center for Individualized Medicine discover new ways to use genomic information in the diagnosis, treatment and prevention of ...
About this study. Obstructive sleep apnea (OSA) is associated with endothelial dysfunction and the development of cardiovascular disease.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.